Who We Are
Our Platform
- Posters & Publications
Our Pipeline
- Inflammatory Diseases
Patients, Families & Physicians
Investors & Media

Careers
Contact Us

Skip to main content
Skip to footer

Click here to read our Frontiers in Immunology paper on the small intestinal axis

Evelo

Monoclonal microbial EDP1503 induces antitumor responses via gut-mediated activation of both innate and adaptive immunity

Home/Posters/Monoclonal microbial EDP1503 induces antitumor responses via gut-mediated activation of both innate and adaptive immunity

November 11, 2019 by

Footer

Terms of Use/Privacy Policy

© Evelo Biosciences, Inc.
EVELO is a registered U.S. trademark of Evelo Biosciences, Inc.

Follow Us LinkedIn